Thro...
You must be logged in to view the whole article.
Click here if you require signing up
Abbott receives approval for HUMIRA from the United States Food and Drug Administration
FDA lifts partial clinical hold on Idenix's HCV nucleotide inhibitor IDX184
Boston Scientific wins CE Mark for Infinion 16 percutaneous lead
Merck receives FDA approval for JANUMET XR for Type 2 diabetes
Neptune Technologies agrees to stay of litigation in patent lawsuit
Janssen's Zytiga fails to secure NICE recommendation
FDA to grant Priority Review status to ThromboGenics' ocriplasmin